Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Tiplica GS"'
Autor:
Edwards, S, Boffa, MJ, Janier, M, Calzavara‐Pinton, P, Rovati, C, Salavastru, CM, Rongioletti, F, Wollenberg, A, Butacu, AI, Skerlev, M, Tiplica, GS
Publikováno v:
Journal of the European Academy of Dermatology & Venereology; Jan2021, Vol. 35 Issue 1, p17-26, 10p
Publikováno v:
Der Hautarzt; 2020, Vol. 71 Issue 12, p932-943, 12p
Autor:
Trakatelli, M, Siskou, S, Proby, C, Tiplica, GS, Hinrichs, B, Altsitsiadis, E, Kitsou, A, Ferrandiz, L, Aquilina, S, Apap, C, Ulrich, M, Fiorentini, C, Magnoni, C, Vries, Esther, Flohil, Sophie, Kalokasidis, K, Moreno-Ramirez, D, Ruiz-de-Casas, A, Majewski, S, Ranki, A, Pitkanen, S, Saksela, O, Ioannides, D, Sotiriadis, D, Stockfleth, E
Publikováno v:
British Journal of Dermatology, 167, 43-52. Wiley-Blackwell Publishing Ltd
Background There are poorly documented variations in the journey a skin cancer patient will follow from diagnosis to treatment in the European Union. Objectives To investigate the possible difficulties or obstacles that a person with a skin malignanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::21addefe50d10bc7859ec9339453e668
https://pure.eur.nl/en/publications/167ab839-e3b2-4887-a524-e06e5cc96cb7
https://pure.eur.nl/en/publications/167ab839-e3b2-4887-a524-e06e5cc96cb7
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single-centre experience.
Autor:
Salavastru CM; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Paediatric Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania., Cretu S; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Dermatology Research Unit, Colentina Clinical Hospital, Bucharest, Romania., Dascalu M; Department of Computer Science, National University of Science and Technology POLITEHNICA Bucharest, Bucharest, Romania., Sendrea AM; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Paediatric Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.; Dermatology Research Unit, Colentina Clinical Hospital, Bucharest, Romania., Suru A; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; Paediatric Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.; Dermatology Research Unit, Colentina Clinical Hospital, Bucharest, Romania., Tiplica GS; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.; 2nd Dermatology Department, Colentina Clinical Hospital, Bucharest, Romania.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov; Vol. 38 (11), pp. e997-e999. Date of Electronic Publication: 2024 May 04.
Autor:
Tetart F; Department of Dermatology and Allergology, Charles Nicolle University Hospital, Rouen, France.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France., Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, King's College Hospital, London, UK., Milpied B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Gaspar K; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Vorobyev A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.; Department of Dermatology, University Medical Center Schleswig-Holstein, Lübeck, Germany., Tiplica GS; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Didona B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Center of Rare Diseases IDI-IRCCS-Rome, Rome, Italy., Welfringer-Morin A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Kucinskiene V; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania., Bensaid B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Edouard Herriot University Hospital, Lyon, France., Marvanova E; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Salavastru C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Brezinova E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospitals Birmingham, Birmingham, UK., Lovgren ML; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Hammers CM; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Christian-Albrechts-University Kiel, Kiel, Germany., Barbaud A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Paris, France., Mortz CG; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Horvath B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Meyersburg D; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria., Lebrun-Vignes B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France., Bodemer C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Brüggen MC; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education Davos (CK-CARE), Davos, Switzerland., French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Ingen-Housz-Oro S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, AP-HP, Henri Mondor University Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov; Vol. 38 (11), pp. 2073-2081. Date of Electronic Publication: 2024 Jul 18.
Autor:
Tanasov A; Dermatology 2, Colentina Clinical Hospital, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania., Tiplica GS; Dermatology 2, Colentina Clinical Hospital, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Publikováno v:
International journal of dermatology [Int J Dermatol] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Manole I; 2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania., Butacu AI; 2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania.; 2nd Department of Dermatology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania., Bejan RN; Adobe Romania, 061331 Bucharest, Romania., Tiplica GS; 2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania.; 2nd Department of Dermatology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Publikováno v:
Bioengineering (Basel, Switzerland) [Bioengineering (Basel)] 2024 Aug 09; Vol. 11 (8). Date of Electronic Publication: 2024 Aug 09.
Autor:
Brüggen MC; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France., Walsh S; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, King's College Hospital, London, England, United Kingdom., Ameri MM; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland., Anasiewicz N; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Maverakis E; Department of Dermatology, University of California, Davis, Sacramento, California., French LE; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.; Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida., Ingen-Housz-Oro S; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France.; Toxic Bullous Dermatoses TOXIBUL Reference Center, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France., Abe R; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Ardern-Jones M; Department of Dermatology, Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, England, United Kingdom., Assier H; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France., Barbaud A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hospital, Department of Dermatology and Allergology, Paris, France., Bensaid B; Department of Dermatology, Lyon Natecia Hospital, Lyon, France., Bernal W; Liver Intensive Therapy Unit, King's Critical Care, King's College Hospital, London, England, United Kingdom., Bernier C; Department of Dermatology, University Hospital Nantes, Nantes, France., Brassard A; Department of Dermatology, University of California, Davis, Sacramento, California., Brezinová E; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatovenereology, St Anne's Faculty Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Cabañas R; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.; PIELenRed Consortium, Madrid, Spain.; Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain., Cardones A; Department of Dermatology, University of Kansas, Kansas City., Chu CY; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Chua SL; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, University of California, San Francisco., Descamps V; Department of Dermatology, Bichat-Claude Bernard Hospital, Paris Diderot University, Paris, France., Didona B; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Center of Rare Diseases IDI-IRCCS, Rome, Italy., Divito SJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Dodiuk-Gad R; Department of Dermatology, Emek Medical Center, Afula, Israel.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Elman S; Department of Dermatology, Miller School of Medicine, University of Miami, Miami, Florida., Gaspar K; Department of Dermatology, University of Debrecen, Debrecen, Hungary., Mortz CG; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Hama N; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Lee HY; Department of Dermatology, Singapore General Hospital, Singapore, Singapore., Horváth B; Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jörg L; Division of Allergology and Clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Kaffenberger BH; Department of Dermatology, The Ohio State University, Columbus, Ohio., Kucinskiene V; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania., Lebrun-Vignes B; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France., Lehloenya RJ; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Meyersburg D; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria., Micheletti R; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Images in Dermatology Editor, JAMA Dermatology., Milpied B; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Center, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Miyagawa F; Department of Dermatology, Nara Medical University, Kashihara, Japan., Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Nägeli M; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Naldi L; Department of Dermatology, Ospedale San Bortolo, Vicenza, Italy., Oppel E; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany., Phillips EJ; Department of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee., Pirani T; Liver Intensive Therapy Unit, King's Critical Care, King's College Hospital, London, England, United Kingdom., Ranki A; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Mälkönen T; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Rosenbach M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Salavastru C; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Staumont-Salle D; CHU Lille, Department of Dermatology, Univ Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE) F-59000, Lille, France., Sandberg H; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Setterfield J; Department of Oral Medicine, Guy's and St Thomas' NHS Foundation Trust, London, England, United Kingdom., Shinkai K; Department of Dermatology, University of California, San Francisco.; Editor, JAMA Dermatology., Shiohara T; Department of Dermatology, Kyorin University School of Medicine, Mitaka, Japan., Soria A; Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Universite, Paris, France., Tartar D; Department of Dermatology, University of California, Davis, Sacramento, California., Tiplica GS; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Traidl S; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Vorobyev A; Department of Dermatology, University Hospital Lübeck, Lübeck, Germany., von Wachter C; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Worswick S; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles., Cho YT; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Publikováno v:
JAMA dermatology [JAMA Dermatol] 2024 Jan 01; Vol. 160 (1), pp. 37-44.
Autor:
Mitjà O; Sexually Transmitted Infections and Skin Neglected Tropical Diseases Section, Fight Infectious Diseases Foundation, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Suñer C; Sexually Transmitted Infections and Skin Neglected Tropical Diseases Section, Fight Infectious Diseases Foundation, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Giacani L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, United States of America.; Department of Global Health, University of Washington, Seattle, WA, United States of America., Vall-Mayans M; Sexually Transmitted Infections and Skin Neglected Tropical Diseases Section, Fight Infectious Diseases Foundation, Hospital Germans Trias i Pujol, Badalona, Spain., Tiplica GS; Dermatology 2, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Ross JDC; Sexual Health and HIV, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Bradshaw CS; Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia.; Central Clinical School, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Publikováno v:
The Lancet regional health. Europe [Lancet Reg Health Eur] 2023 Oct 26; Vol. 34, pp. 100737. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).
Autor:
Fritz K; Carol Davila University of Medicine and Pharmacy, Bucharest, Rumänien. drklausfritz@drklausfritz.com.; Dermatology and Laser Consultation Center, Landau, Deutschland. drklausfritz@drklausfritz.com., Tiplica GS; Carol Davila University of Medicine and Pharmacy, Bucharest, Rumänien.; Colentina Clinical Hospital, Bucharest, Rumänien., Salavastru C; Carol Davila University of Medicine and Pharmacy, Bucharest, Rumänien.; Colentina Clinical Hospital, Bucharest, Rumänien.; Pediatric Dermatology Discipline, Dermato-oncology Research Facility, Bucharest, Rumänien.
Publikováno v:
Dermatologie (Heidelberg, Germany) [Dermatologie (Heidelb)] 2023 Oct; Vol. 74 (10), pp. 740-747. Date of Electronic Publication: 2023 Aug 15.